ENTtoday
  • Home
  • COVID-19
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Rx: Wellness
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

Promise for Recurrent Respiratory Papillomatosis: Pediatric otolaryngologists have high hopes for the HPV vaccine

by Thomas R. Collins • July 2, 2010

  • Tweet
  • Email
Print-Friendly Version

Experts say that no evidence from Merck’s trials has shown this to be the case, but it is theoretically possible that the vaccine might have a therapeutic effect.

You Might Also Like

  • Pediatric Recurrent Respiratory Papillomatosis: Fighting the Battle of a Rare But Serious Disease
  • Recurrent Respiratory Papillomatosis: Much Has Been Done, but a Long Road Lies Ahead
  • Recurrent Respiratory Papillomatosis: Researchers Advancing Toward Prevention
  • Prevalence of Dysplasia with Recurrent Respiratory Papillomatosis Is High
Explore This Issue
July 2010

Douglas Lowy, MD, an expert on the HPV vaccine for the National Cancer Institute, called on otolaryngologists to test the possibility in controlled trials. “What I do think would be worthwhile for the otolaryngology community to consider is the possibility of a controlled trial in children with newly diagnosed RRP, a controlled trial of the vaccine,” Dr. Lowry said. “The goal would be to try to reduce the likelihood of spread to new areas,” he said, pointing out that he was speaking for himself and not the government. “I have no idea whether it would work or it wouldn’t work but it seems to me that this is a serious enough condition that… it would be worth considering it.”

Farrel Buchinsky, MD, assistant professor of surgery at Drexel University College of Medicine, is now studying antibody response in both vaccinated and unvaccinated RRP patients. He hopes the study can show whether further work investigating a therapeutic use of the vaccine is worthwhile.

“We have the data, and I’m busy analyzing,” said Dr. Buchinsky, who anticipates finishing a manuscript for the study in the coming months. “Even if there is great data, it still may or may not work. What this data will do is serve to increase or decrease enthusiasms for a therapeutic trial.”

Experts on the disease agree that the vaccine should not be used for preventing the spread of lesions until solid research has been finished.

“When people inquire to me about this,” said Craig Derkay, MD, professor of otolaryngology and pediatrics at Eastern Virginia Medical School, “I tell them that we really should study this in a way that we pool the data and answer this in a scientific fashion. There have been a lot of false starts in the treatment of RRP over the years.”

—Thomas R. Collins

Pages: 1 2 3 4 | Single Page

Filed Under: Departments, Head and Neck, Pediatric, Practice Focus Tagged With: HPV, human papillomavirus (HPV), pediatric otolaryngology, pediatrics, respiratory, sexually transmitted diseases, vaccineIssue: July 2010

You Might Also Like:

  • Pediatric Recurrent Respiratory Papillomatosis: Fighting the Battle of a Rare But Serious Disease
  • Recurrent Respiratory Papillomatosis: Much Has Been Done, but a Long Road Lies Ahead
  • Recurrent Respiratory Papillomatosis: Researchers Advancing Toward Prevention
  • Prevalence of Dysplasia with Recurrent Respiratory Papillomatosis Is High

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Why More MDs, Medical Residents Are Choosing to Pursue Additional Academic Degrees
  • What Physicians Need to Know about Investing Before Hiring a Financial Advisor
  • Tips to Help You Regain Your Sense of Self
  • Should USMLE Step 1 Change from Numeric Score to Pass/Fail?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • Experts Delve into Treatment Options for Laryngopharyngeal Reflux
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Weaning Patients Off of PPIs
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Vertigo in the Elderly: What Does It Mean?
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Podcasts Becoming More Popular Method of Education for Otolaryngologists
    • How to Embrace Optimism in the Midst of the COVID-19 Pandemic
    • Tips on How to Approach Conversations with Patients about the COVID-19 Vaccine
    • Steps You Should Take to Protect Your Voice and Hearing During Telemedicine Sessions
    • Routine Postoperative Adjunct Treatments Unnecessary for Idiopathic Cerebrospinal Fluid Leaks

Polls

Have you spoken with your patients about receiving the COVID-19 vaccine?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms of Use

Visit: The Triological Society • The Laryngoscope • Laryngoscope Investigative Otolaryngology

Wiley
© 2021 The Triological Society. All Rights Reserved.
ISSN 1559-4939

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.